Evidence map›Paper›PMID 40835873›Full record

ArticleScientific reports2025

The effect of age-related sensorimotor changes on step-down strategy: a predictive simulation study.

Lucas Schreff, Niels F J Waterval, Marjolein M van der Krogt, Daniel F B Häufle, Roy Müller

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lucas SchreffDepartment of Orthopedic Surgery, Klinikum Bayreuth GmbH, Bayreuth, Germany. Lucas.schreff@gmx.de.
Niels F J WatervalAmsterdam Movement Sciences, Rehabilitation and Development, Amsterdam, The Netherlands.
Marjolein M van der KrogtAmsterdam Movement Sciences, Rehabilitation and Development, Amsterdam, The Netherlands.
Daniel F B Häufle *Hertie Institute for Clinical Brain Research and Center for Integrative Neuroscience, Tübingen, Germany.
Roy Müller *Department of Orthopedic Surgery, Klinikum Bayreuth GmbH, Bayreuth, Germany. Roy.mueller@klinikum-bayreuth.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humans adjust neuromuscular control in anticipation of a step-down during walking. Due to age-related sensorimotor changes, older adults may require adaptation of this control to step-down safely. We used predictive simulations to investigate how muscle weakness and delayed neural transmission affect anticipatory control during step-down. Five model variants were developed: a default model, two with muscle strength reduced to 80% and 60%, and two with neural delays increased by 20% and 40%. For each model, we tested two strategies in the trailing leg during the last contact before step-down: reduced soleus activity (SOL strategy) and increased hamstring activity (HAM strategy). We systematically varied step-down height and anticipatory control levels. For the SOL strategy, both muscle weakness and neural delay reduced the maximum feasible step-down height, with muscle weakness requiring more precise adjustments. The HAM strategy was mainly affected by neural delay and showed less sensitivity to control precision. While the SOL strategy generally performed better, the HAM strategy was more robust under severe weakness. These results suggest that the HAM strategy may benefit individuals with progressive sensorimotor decline, while maintaining SOL strategy applicability-e.g., through strength training-could help maintain its benefits. Further investigations are needed to confirm this.

Indexed as

AgingWalkingAdultAgedComputer SimulationFemaleHumansMaleMiddle AgedMuscle, SkeletalMuscle StrengthMuscle WeaknessAgingAnticipationElderly walkingHuman gaitNeuromusculoskeletal modelOptimization

Identifiers

PMID40835873
PMCPMC12368066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.